Instil Bio, Inc. (Nasdaq: TIL) (“Instil”) today announced that Axion Bio, Inc. (“Axion”), a wholly-owned subsidiary of Instil, has decided to discontinue clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback